ArticleOncoimmunology2021

Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis.

Serika D Naicker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.